Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025040. https://doi.org/10.4084/MJHID.2025.040.